U.S. Specialty Stores Stock News

If you are wondering whether SLB at around US$56.15 still offers value or is starting to look stretched, the key is to look past the headline share price and focus on what different valuation methods are saying. Over the short term, the stock has returned 6.6% over 7 days and 8.2% over 30 days, while the year to date return stands at 39.7% and the 1 year return at 67.6%. This may have shifted how investors view both its potential and its risks. Recent coverage has focused on how SLB fits...

Wondering if Opera's recent share price puts it in the bargain bin or the overhyped aisle? This article breaks down what the numbers say about value. At a last close of US$17.23, Opera's share price comes with recent returns of 0.6% over 7 days, 25.6% over 30 days, 21.1% year to date, 16.3% over 1 year, 67.0% over 3 years, and 105.9% over 5 years. These moves sit against a backdrop of ongoing interest in Opera as a software name, with headlines frequently focusing on its role as a browser...

In April 2026, Graham Corporation disclosed a private placement under a Securities Purchase Agreement with T. Rowe Price Investment Management and 13 other accredited investors, issuing 599,808 common shares at US$83.36 each for gross proceeds of US$49,999,994.88 under a Regulation D exemption. This institutional-led funding round not only brings in substantial new equity capital but also signals external investor confidence in Graham’s capital allocation and longer-term growth...

Wondering if Amkor Technology at US$78.10 is priced for perfection or still offers value? This article walks you through what the current market price may be telling you. The stock has recently posted returns of 15.9% over 7 days, 73.0% over 30 days, 82.0% year to date, and 350.3% over 1 year, which can change how investors think about both upside potential and risk. These moves sit against the backdrop of ongoing attention on semiconductor supply chains and packaging capacity, as investors...

Wondering whether Palvella Therapeutics at around US$123.59 still offers value, or if most of the easy gains are already behind it? This article walks through what the current price could mean for you. The stock has seen a 23.2% return year to date and a 386.8% return over the last year, alongside shorter term moves of a 2.7% return over 30 days and a 4.9% decline over the past week. Recent attention on Palvella Therapeutics has centered on how the market is reassessing smaller biotech names...

If you are wondering whether Royal Gold's current share price offers fair value or a potential mispricing, this article walks through the key signals that matter for you as a shareholder or prospective buyer. The stock recently closed at US$252.36, with returns of 8.3% over 30 days, 14.1% year to date, 42.3% over 1 year, 97.2% over 3 years, and 139.2% over 5 years. This naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on...

In April 2026, ZenaTech expanded its global drone and SaaS footprint by registering Phoenix Aero in Lviv, Ukraine, and opening new offices in Seoul and London to support manufacturing, counter-UAS testing, and regional commercial, government, and defense operations. This rapid build-out of on-the-ground teams across EMEA and APAC highlights ZenaTech’s intent to become a key provider of AI-driven autonomous drone solutions and recurring software services in multiple high-demand markets. We’ll...

If you are wondering whether Ciena's current share price reflects its true worth, the recent trading history gives you plenty to think about. The stock last closed at US$520.80, with returns of 2.6% over 7 days, 19.0% over 30 days and 111.7% year to date, plus very large returns over 1 year and the past 3 and 5 years. Recent coverage has focused on Ciena as a key player in communications technology, with attention on how its products fit into growing data and network demand. This context has...

Varonis Systems launched Atlas, an all in one AI security solution integrated with its Data Security Platform. Atlas is designed to help enterprises with AI inventory discovery, security testing, data leak prevention, and compliance. The launch adds a new AI focused layer to Varonis Systems' existing data security offering. For investors watching NasdaqGS:VRNS, Atlas lands at a time when AI security is a central concern for many enterprise IT teams. The company’s shares most recently closed...

DHT Holdings (DHT) has attracted investor attention after recent share price moves, with the stock closing at US$18.06. You might be weighing what the tanker operator’s performance metrics imply for future risk and reward. See our latest analysis for DHT Holdings. Recent trading has been choppy, with a 1.52% 1 day share price return and a 7 day share price return of 1.42%. This compares with a much stronger 90 day share price return of 30.68% and a year to date share price return of 53.83%,...

If you are wondering whether Wintrust Financial at US$147.91 still offers value or is starting to look stretched, the recent share price and fundamentals give you some clear clues to work with. The stock has held up over the last week with a 0.2% decline. The 30 day return sits at 8.0% and the 1 year return at 35.6%, with longer term returns of 128.2% over 3 years and 108.7% over 5 years. Recent coverage has focused on Wintrust Financial as part of broader discussions around US regional...

Why Getty Realty Stock Is Drawing Attention Now Getty Realty (GTY) has been on some investors’ radar after a stretch of positive total returns over the past year, prompting closer scrutiny of its income profile and recent share performance. See our latest analysis for Getty Realty. Getty Realty’s share price has eased slightly in the very short term, with a 1 day share price return of 0.92% decline and a 7 day share price return of 3.35% decline. However, the 90 day share price return of...

Investors wondering if Pegasystems at about US$37.33 is starting to look like value or still has more to fall can use this article to walk through what the current share price might be implying. The stock has seen a 14.4% decline over the last 7 days, a 10.0% decline over the last 30 days, and is down 33.4% year to date, although the 3 year return sits at 64.7% while the 5 year return is a 40.6% decline. These mixed returns sit against an ongoing investor focus on software names, and...

Earlier this year, Elanco Animal Health reported a 12.2% year-on-year revenue increase that surpassed analysts’ expectations, while at the same time issuing earnings-per-share guidance for the upcoming quarter that fell short of forecasts. This combination of stronger sales momentum and a weaker profit outlook highlights the tension between Elanco’s growth investments and its near-term earnings profile. We’ll now examine how Elanco’s stronger-than-expected revenue growth but softer EPS...

FDA extends Priority Review for Savara’s molgramostim BLA in autoimmune PAP by three months following a major amendment. Regulator cites no new safety, efficacy, or manufacturing concerns in connection with the extension. Extension reflects ongoing review activity for Savara’s lead product candidate, ticker NasdaqGS:SVRA. Savara, listed on NasdaqGS:SVRA, focuses on therapies for rare respiratory diseases, with molgramostim as its most advanced program targeting autoimmune pulmonary alveolar...

If you are wondering whether CNO Financial Group's current share price reflects its true worth, you are not alone. This article focuses squarely on what the numbers say about value. The stock most recently closed at US$43.71, with returns of 0.2% over 7 days, 7.6% over 30 days, 3.6% year to date, 12.3% over 1 year, 106.9% over 3 years and 90.8% over 5 years. This provides plenty of history to measure current pricing against. Recent coverage around CNO Financial Group has centered on its role...

Vail Resorts (NYSE:MTN) reports that an unusually warm winter and record low snowfall have sharply reduced skier visits across its resorts. The company now expects full year results to come in near the lower end of its previously issued guidance. Weather driven disruption to skier visitation is creating a material headwind for resort revenue and in resort spending. For investors watching Vail Resorts, the operational setback comes on top of a weak share price backdrop. NYSE:MTN closed at...

If you are wondering whether ANI Pharmaceuticals at around US$78.64 is priced attractively or already reflects a lot of optimism, the starting point is to understand what the current share price implies about future expectations. The stock shows mixed recent returns, with a 2.8% decline over 7 days, a 6.2% gain over 30 days, a 0.3% return year to date, 12.6% over 1 year, 108.5% over 3 years and 136.3% over 5 years. Recent coverage around ANI Pharmaceuticals has focused on its position within...

If you are wondering whether TransMedics Group at around US$110.93 is still priced attractively or already baking in a lot of optimism, this article walks through the key valuation clues. The stock has had a mixed recent run, with a 4.3% pullback over the last 7 days, an 8.5% gain over 30 days, a 9.6% decline year to date, an 18.6% return over the past year, and a very large 3 year gain of around 40.2%. Recent headlines around TransMedics Group have continued to focus on its position in the...

Hong Leong Bank recently announced a partnership with Tencent Music Entertainment Group’s JOOX and QQ Music to co-present the AsiaTop Music Festival 2026, held on 30 and 31 May 2026 at Malaysia’s Sepang International Circuit with leading Malaysian, Asian and K‑pop acts and exclusive privileges for its cardholders. This collaboration ties Tencent Music’s platforms more closely to offline fan experiences and financial services, potentially deepening regional brand reach and user engagement...

Innovative Aerosystems has acquired an exclusive perpetual license from Honeywell International (NasdaqGS:HON) for aircraft power generating systems. The transaction covers customer contracts, intellectual property rights, and both OEM and aftermarket assets tied to these systems. This move reshapes how Honeywell participates in aircraft power technologies across commercial and defense programs. For you as an investor, this is a focused portfolio move within Honeywell's aerospace business...

Philip Morris International Inc. reported past first-quarter 2026 results with revenue rising to US$10.15 billion from US$9.30 billion, while net income and diluted EPS from continuing operations eased to US$2.44 billion and US$1.56 respectively, and it updated full-year 2026 EPS guidance to US$7.56–US$7.71. Beyond the headline numbers, the quarter underscored how growth in smoke-free products like IQOS and VEEV, supported by pricing power, is reshaping Philip Morris International’s earnings...

How Tripadvisor’s Recent Performance Frames Today’s Valuation Debate Tripadvisor (TRIP) is back on many watchlists after a mixed run, with the share price up over the past month but lower across the past 3 months and year to date. Investors are weighing that pattern against the company’s latest fundamentals. See our latest analysis for Tripadvisor. At a share price of US$11.19, Tripadvisor’s recent pattern shows a strong 30 day share price return of 17.67% alongside a weaker 90 day share...

If you are wondering whether Viking Holdings at US$81.82 is still reasonably priced after a strong run, the key question is how that share price compares with the company’s underlying value. The stock has seen a 13.2% return year to date and a 101.8% return over the last 1 year, with a recent 9.8% move over 30 days followed by a 4.6% pullback over the past week, which can change how investors think about both upside potential and risk. Recent coverage has focused on Viking Holdings as a...